Skip to main content
Tech.euFundingExplorerBeta

NovImmune

Develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders

Plan-les-Ouates, SwitzerlandFounded 1998novimmune.com ↗
Healthtech
← All companies
Total raised
€218M
€217,727,269
Funding rounds
7
Investors
7
distinct backers
Active since
2000-04
latest 2015-12

Funding by year

EUR raised per year

Signals

Medium confidence
Raise-next likelihood18
base rate 53% for Series D+
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Down/flat last round
Exit likelihood28
base rate 12% (2+ rounds)
  • ▲ 7 rounds raised
  • ▲ €100M+ raised
  • ▲ 28y since founding

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

7 rounds
DateStageAmountInvestors
2016-01-01Series D+€27M—View deal →
2014-02-01Series D+€60MRosetta CapitalView deal →
2012-10-01Grant€6.0M—View deal →
2010-12-01Series D+€20MBZ BankView deal →
2009-05-01Series C€50MAravis Ventures,BZ Bank,LODH Immunology Fund,Novartis Venture Fund,Pictet,VarumaView deal →
2006-06-01Series B€42MAravis Ventures,LODH Immunology Fund,Novartis Venture Fund,PictetView deal →
2000-05-01Series A€13MLODH Immunology Fund,Novartis Venture FundView deal →

Investors

7
Aravis VenturesBZ BankLODH Immunology FundNovartis Venture FundPictetRosetta CapitalVaruma

Related news

Similar companies

same sector or country